Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular endocytic machinery is a complex, highly regulated system of proteins and lipids responsible for the internalization of extracellular materials, plasma membrane proteins, and lipids into the cell (Doherty & McMahon, 2009, Nature). This machinery includes various pathways such as clathrin-mediated endocytosis (CME), caveolae-mediated endocytosis, and macropinocytosis, involving key proteins like clathrin, dynamin, and adaptor protein complexes (Conner & Schmid, 2003, Nature). Biologically, it is essential for nutrient uptake, signal transduction regulation via receptor internalization, and maintaining membrane homeostasis (McMahon & Boucrot, 2011, Nat Rev Mol Cell Biol). In disease, the endocytic machinery is often hijacked by pathogens, including viruses like SARS-CoV-2 and Influenza, for cellular entry (Marsh & Helenius, 2006, Cell). It is also frequently dysregulated in cancers to maintain growth factor signaling and promote metastasis (Mellman & Yarden, 2013, Cold Spring Harb Perspect Biol). While specific components like dynamin are targets for research tools such as dynasore, the broad nature of the machinery presents significant therapeutic challenges due to potential systemic toxicity and lack of specificity (Macia et al., 2006, Dev Cell).
Drugs targeting the endocytic machinery typically act by inhibiting specific protein-protein interactions (e.g., clathrin-adaptor binding), blocking enzymatic activities required for membrane fission such as dynamin GTPase activity, or altering the chemical environment of endocytic vesicles like endosomal pH neutralization (Dutta & Donaldson, 2012, Cell Logist).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular endocytic machinery.